001     142744
005     20240229105152.0
024 7 _ |2 doi
|a 10.1038/s41467-017-02763-y
024 7 _ |2 pmid
|a pmid:29367624
024 7 _ |2 pmc
|a pmc:PMC5783942
024 7 _ |a altmetric:32164515
|2 altmetric
037 _ _ |a DKFZ-2019-00461
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Raposo, Bruno
|b 0
245 _ _ |a T cells specific for post-translational modifications escape intrathymic tolerance induction.
260 _ _ |a [London]
|b Nature Publishing Group UK
|c 2018
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1550666893_25980
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Establishing effective central tolerance requires the promiscuous expression of tissue-restricted antigens by medullary thymic epithelial cells. However, whether central tolerance also extends to post-translationally modified proteins is not clear. Here we show a mouse model of autoimmunity in which disease development is dependent on post-translational modification (PTM) of the tissue-restricted self-antigen collagen type II. T cells specific for the non-modified antigen undergo efficient central tolerance. By contrast, PTM-reactive T cells escape thymic selection, though the PTM variant constitutes the dominant form in the periphery. This finding implies that the PTM protein is absent in the thymus, or present at concentrations insufficient to induce negative selection of developing thymocytes and explains the lower level of tolerance induction against the PTM antigen. As the majority of self-antigens are post-translationally modified, these data raise the possibility that T cells specific for other self-antigens naturally subjected to PTM may escape central tolerance induction by a similar mechanism.
536 _ _ |0 G:(DE-HGF)POF3-314
|a 314 - Tumor immunology (POF3-314)
|c POF3-314
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |2 NLM Chemicals
|a Autoantigens
650 _ 7 |2 NLM Chemicals
|a Collagen Type II
700 1 _ |a Merky, Patrick
|b 1
700 1 _ |a Lundqvist, Christina
|b 2
700 1 _ |a Yamada, Hisakata
|b 3
700 1 _ |a Urbonaviciute, Vilma
|b 4
700 1 _ |a Niaudet, Colin
|b 5
700 1 _ |a Viljanen, Johan
|b 6
700 1 _ |a Kihlberg, Jan
|b 7
700 1 _ |0 P:(DE-He78)08a57258198dcedd8ff8ac7eef40341a
|a Kyewski, Bruno
|b 8
|u dkfz
700 1 _ |0 0000-0002-4506-9955
|a Ekwall, Olov
|b 9
700 1 _ |0 0000-0002-4969-2576
|a Holmdahl, Rikard
|b 10
700 1 _ |a Bäcklund, Johan
|b 11
773 _ _ |0 PERI:(DE-600)2553671-0
|a 10.1038/s41467-017-02763-y
|g Vol. 9, no. 1, p. 353
|n 1
|p 353
|t Nature Communications
|v 9
|x 2041-1723
|y 2018
909 C O |o oai:inrepo02.dkfz.de:142744
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)08a57258198dcedd8ff8ac7eef40341a
|a Deutsches Krebsforschungszentrum
|b 8
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF3-314
|1 G:(DE-HGF)POF3-310
|2 G:(DE-HGF)POF3-300
|a DE-HGF
|l Krebsforschung
|v Tumor immunology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b NAT COMMUN : 2017
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Blind peer review
915 _ _ |0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|a Creative Commons Attribution CC BY (No Version)
|b DOAJ
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)1060
|2 StatID
|a DBCoverage
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)1040
|2 StatID
|a DBCoverage
|b Zoological Record
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9910
|2 StatID
|a IF >= 10
|b NAT COMMUN : 2017
920 1 _ |0 I:(DE-He78)D090-20160331
|k D090
|l Entwicklungsimmunologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D090-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21